Sutro Biopharma, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
1/10
|
85.38 | 48.72 | 75.24% | 11.32 | +654.19% |
| P/S |
|
1.65 | 33.75 | -95.12% |
|
|
| P/BV |
|
1.69 | 4.82 | -64.87% |
|
|
| P/FCF |
|
-2.29 | 61 | -103.75% |
|
|
| Ev/Ebitda |
|
-4.45 | -22.17 | -79.94% |
|
|
| Ev/S |
|
2.39 | 22.56 | -89.42% |
|
|
| Ev/FCF |
|
-3.16 | 68.75 | -104.6% |
|
|
| E/P |
|
-0.4027 | 0.0178 | -2365.71% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-53.64 | 4.98 | -1177.78% | -122.3 | -56.14% |
| ROE |
|
-71.36 | 9.61 | -842.46% |
|
|
| ROA |
|
-22.69 | 0.3443 | -6689.91% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-69.47 | -25.17 | 176% |
|
|
| ROCE |
|
-55.22 | 15.35 | -459.7% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-2.22 | -3.68 | -39.71% | -1.17 | +89.38% |
| Nеt Debt/Ebitda |
|
-1.38 | -3.44 | -59.96% |
|
|
| Debt/Ratio |
|
0.3882 | 0.1985 | 95.59% |
|
|
| Debt/Equity |
|
0.5905 | 1.66 | -64.48% |
|
|
| Debt/Net Income |
|
-1.71 | 10.32 | -116.58% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5473 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 1.07 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.498 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5473 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
260.03 | -56.89 | -557.08% | ||
| Growth impulse Ebitda in 5 years |
|
45.74 | -54.68 | -183.65% | ||
| Growth impulse Net Income in 5 years |
|
90.7 | -58.33 | -255.49% | ||
| Growth impulse FCF in 5 years |
|
69.24 | -49.48 | -239.94% | ||
| Growth impulse EPS in 5 years |
|
-27.25 | -32.41 | -15.92% |
IP Score
4.46/10
